Product Code: GVR-4-68040-128-1
Egg Freezing And Embryo Banking Market Growth & Trends:
The global egg freezing and embryo banking market size is expected to reach USD 13.8 billion by 2030, based on a new report by Grand View Research, Inc.., exhibiting a CAGR of 16.80% during the forecast period. The market for egg freezing and embryo banking is projected to experience significant growth due to advancements in medical technology and improvements in the egg-freezing process that have made it a more reliable and viable option. As fertility treatment success improves, more women consider egg freezing for fertility preservation.
Egg freezing and embryo banking offer various benefits such as reproductive flexibility, extended family planning, and medical adaptability. These advantages enhance family planning options, reduce time pressure on family-building decisions, and boost emotional well-being, driving market growth. In May 2022, a study published by NYU Grossman School of Medicine and NYU Langone Fertility Center demonstrated a 70% success rate in having a child for women who froze eggs before 38 years of age and thawed at least 20 eggs, spanning 15 years of real-life outcomes. With 211 babies born, these findings underscore the efficacy of egg-freezing technology, highlighting its importance in enhancing reproductive success.
As awareness grows and technology improves further, the market is projected to expand in the coming years. The surging demand for egg freezing and embryo banking, combined with strategic partnerships among major players, is propelling significant growth in the market, enriching healthcare options for those in need.
For instance, in April 2023, CCRM Fertility, a global leader in fertility treatment and research, announced its acquisition of The New Hope Center for Reproductive Medicine, a fertility clinic based in Virginia Beach, Virginia. This expansion broadens CCRM Fertility's presence on the East Coast of the U.S., facilitating easier access to innovative fertility treatments, comprehensive testing, advanced laboratories, and in-house genetics and research. The development is poised to contribute to the advancement of fertility care and treatment options.
Egg Freezing And Embryo Banking Market Report Highlights:
- Based on type, the segments included are donor and nondonor. The nondonor segment held the larger revenue share of over 53% in 2022, due to its inclusion of procedures involving women's own eggs, which generally comprise the majority of fertility preservation cases
- In terms of preservation, the market is categorized into egg freezing and embryo freezing. The embryo freezing segment held the largest revenue share of 71.8% in 2022 due to several factors. Egg freezing offers women the flexibility to preserve their fertility potential for a longer period, especially as a response to career priorities or medical concerns
- Based on the age of patients, the segment is categorized as under 35, 35-37, 38-40, and over 42. The segment over 35 tends to have a higher inclination towards egg freezing. This age range typically represents women who are approaching their late 30s and early 40s, a time when fertility starts to decline more rapidly
- Europe dominated the market and accounted for the maximum revenue share of over 36% in 2022. This can be primarily attributed to the well-established presence and contribution of the region in the field of assisted reproduction technology
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Market Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources & Third-Party Perspectives
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.1.1. Delayed Childbearing due to Sociodemographic Factors
- 3.3.1.2. Increasing Rate of Infertilities
- 3.3.1.3. Increasing Awareness in Reproductive Health
- 3.3.2. Market Restraint Analysis
- 3.3.2.1. Ethical Concerns About the Preservation of Eggs and Sperms
- 3.3.2.2. High cost associated with banking
- 3.4. Business Environment Analysis
- 3.4.1. PESTLE Analysis
- 3.4.2. Porter's Five Forces Analysis
- 3.5. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
- 4.1. Egg Freezing and Embryo Banking Market: Type Segment Dashboard
- 4.2. Type Movement Analysis, 2022 & 2030
- 4.2.1. Donor
- 4.2.1.1. Donor Market, 2018 - 2030 (USD Million)
- 4.2.2. Nondonor
- 4.2.2.1. Nondonor Market, 2018 - 2030 (USD Million)
Chapter 5. Preservation Business Analysis
- 5.1. Egg Freezing and Embryo Banking Market: Preservation Segment Dashboard
- 5.2. Preservation Movement Analysis, 2022 & 2030
- 5.2.1. Egg Freezing
- 5.2.1.1. Egg Freezing Market, 2018 - 2030 (USD Million)
- 5.2.2. Embryo Freezing
- 5.2.2.1. Embryo Freezing Market, 2018 - 2030 (USD Million)
Chapter 6. Age of Patient Business Analysis
- 6.1. Egg Freezing and Embryo Banking Market: Age of Patient Segment Dashboard
- 6.2. Age of Patient Movement Analysis, 2022 & 2030
- 6.2.1. Under 35
- 6.2.2. Under 35 Market, 2018 - 2030 (USD Million)
- 6.2.3. 35-37
- 6.2.3.1. 35-37 Market, 2018 - 2030 (USD Million)
- 6.2.4. 38-40
- 6.2.5. 38-40 Market, 2018 - 2030 (USD Million)
- 6.2.6. Over 42
- 6.2.6.1. Over 42 Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Regional Market Snapshot
- 7.2. Market Share Analysis by Country, 2022
- 7.3. North America
- 7.3.1. North America Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. U.S. Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.3.2.2. Key Country Dynamics
- 7.3.2.3. Regulatory & Reimbursement Framework
- 7.3.2.4. Competitive Scenario
- 7.3.3. Canada
- 7.3.3.1. Canada Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.3.3.2. Key Country Dynamics
- 7.3.3.3. Regulatory & Reimbursement Framework
- 7.3.3.4. Competitive Scenario
- 7.4. Europe
- 7.4.1. Europe Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Germany Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.4.2.2. Key Country Dynamics
- 7.4.2.3. Regulatory & Reimbursement Framework
- 7.4.2.4. Competitive Scenario
- 7.4.3. UK
- 7.4.3.1. UK Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.4.3.2. Key Country Dynamics
- 7.4.3.3. Regulatory & Reimbursement Framework
- 7.4.3.4. Competitive Scenario
- 7.4.4. France
- 7.4.4.1. France Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.4.4.2. Key Country Dynamics
- 7.4.4.3. Regulatory & Reimbursement Framework
- 7.4.4.4. Competitive Scenario
- 7.4.5. Italy
- 7.4.5.1. Italy Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.4.5.2. Key Country Dynamics
- 7.4.5.3. Regulatory & Reimbursement Framework
- 7.4.5.4. Competitive Scenario
- 7.4.6. Spain
- 7.4.6.1. Spain Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.4.6.2. Key Country Dynamics
- 7.4.6.3. Regulatory & Reimbursement Framework
- 7.4.6.4. Competitive Scenario
- 7.4.7. Denmark
- 7.4.7.1. Denmark Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.4.7.2. Key Country Dynamics
- 7.4.7.3. Regulatory & Reimbursement Framework
- 7.4.7.4. Competitive Scenario
- 7.4.8. Sweden
- 7.4.8.1. Sweden Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.4.8.2. Key Country Dynamics
- 7.4.8.3. Regulatory & Reimbursement Framework
- 7.4.8.4. Competitive Scenario
- 7.4.9. Norway
- 7.4.9.1. Norway Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.4.9.2. Key Country Dynamics
- 7.4.9.3. Regulatory & Reimbursement Framework
- 7.4.9.4. Competitive Scenario
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Japan Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.5.2.2. Key Country Dynamics
- 7.5.2.3. Regulatory & Reimbursement Framework
- 7.5.2.4. Competitive Scenario
- 7.5.3. China
- 7.5.3.1. China Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.5.3.2. Key Country Dynamics
- 7.5.3.3. Regulatory & Reimbursement Framework
- 7.5.3.4. Competitive Scenario
- 7.5.4. India
- 7.5.4.1. India Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.5.4.2. Key Country Dynamics
- 7.5.4.3. Regulatory & Reimbursement Framework
- 7.5.4.4. Competitive Scenario
- 7.5.5. South Korea
- 7.5.5.1. South Korea Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.5.5.2. Key Country Dynamics
- 7.5.5.3. Regulatory & Reimbursement Framework
- 7.5.5.4. Competitive Scenario
- 7.5.6. Australia
- 7.5.6.1. Australia Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.5.6.2. Key Country Dynamics
- 7.5.6.3. Regulatory & Reimbursement Framework
- 7.5.6.4. Competitive Scenario
- 7.5.7. Thailand
- 7.5.7.1. Thailand Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.5.7.2. Key Country Dynamics
- 7.5.7.3. Regulatory & Reimbursement Framework
- 7.5.7.4. Competitive Scenario
- 7.6. Latin America
- 7.6.1. Latin America Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Brazil Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.6.2.2. Key Country Dynamics
- 7.6.2.3. Regulatory & Reimbursement Framework
- 7.6.2.4. Competitive Scenario
- 7.6.3. Mexico
- 7.6.3.1. Mexico Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.6.3.2. Key Country Dynamics
- 7.6.3.3. Regulatory & Reimbursement Framework
- 7.6.3.4. Competitive Scenario
- 7.6.4. Argentina
- 7.6.4.1. Argentina Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.6.4.2. Key Country Dynamics
- 7.6.4.3. Regulatory & Reimbursement Framework
- 7.6.4.4. Competitive Scenario
- 7.7. MEA
- 7.7.1. MEA Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. South Africa Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.7.2.2. Key Country Dynamics
- 7.7.2.3. Regulatory & Reimbursement Framework
- 7.7.2.4. Competitive Scenario
- 7.7.3. Saudi Arabia
- 7.7.3.1. Saudi Arabia Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.7.3.2. Key Country Dynamics
- 7.7.3.3. Regulatory & Reimbursement Framework
- 7.7.3.4. Competitive Scenario
- 7.7.4. UAE
- 7.7.4.1. UAE Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.7.4.2. Key Country Dynamics
- 7.7.4.3. Regulatory & Reimbursement Framework
- 7.7.4.4. Competitive Scenario
- 7.7.5. Kuwait
- 7.7.5.1. Kuwait Egg freezing and embryo banking Market, 2018 - 2030 (USD Million)
- 7.7.5.2. Key Country Dynamics
- 7.7.5.3. Regulatory & Reimbursement Framework
- 7.7.5.4. Competitive Scenario
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.2.1. Expansions
- 8.2.2. Acquisitions
- 8.2.3. Collaborations
- 8.2.4. New Product Launches
- 8.2.5. Others
- 8.3. Company Profiles/Listing
- 8.3.1. ReproTech LLC
- 8.3.1.1. Overview
- 8.3.1.2. Financial Performance
- 8.3.1.3. Product Benchmarking
- 8.3.1.4. Strategic Initiatives
- 8.3.2. Cryos International
- 8.3.2.1. Overview
- 8.3.2.2. Financial Performance
- 8.3.2.3. Product Benchmarking
- 8.3.2.4. Strategic Initiatives
- 8.3.3. CCRM Fertility
- 8.3.3.1. Overview
- 8.3.3.2. Financial Performance
- 8.3.3.3. Product Benchmarking
- 8.3.3.4. Strategic Initiatives
- 8.3.4. RMA Network
- 8.3.4.1. Overview
- 8.3.4.2. Financial Performance
- 8.3.4.3. Product Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. Carrot Fertility
- 8.3.5.1. Overview
- 8.3.5.2. Financial Performance
- 8.3.5.3. Product Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. WINFertility
- 8.3.6.1. Overview
- 8.3.6.2. Financial Performance
- 8.3.6.3. Product Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. Columbia University
- 8.3.7.1. Overview
- 8.3.7.2. Financial Performance
- 8.3.7.3. Product Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. Shady Grove Fertility
- 8.3.8.1. Overview
- 8.3.8.2. Financial Performance
- 8.3.8.3. Product Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. Kindbody
- 8.3.9.1. Overview
- 8.3.9.2. Financial Performance
- 8.3.9.3. Product Benchmarking
- 8.3.9.4. Strategic Initiatives